Timber Pharmaceuticals, Inc.·4

Dec 16, 4:23 PM ET

Koconis John 4

4 · Timber Pharmaceuticals, Inc. · Filed Dec 16, 2021

Insider Transaction Report

Form 4
Period: 2021-12-15
Koconis John
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2021-12-15$0.38/sh+20,000$7,68620,000 total

Documents

1 file
  • 4
    tm2135697-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT